Saadh Mohamed J, Ahmed Hanan Hassan, Kareem Radhwan Abdul, Baldaniya Lalji, Verma Lokesh, Prasad G V Siva, Chahar Mamata, Taher Waam Mohammed, Alwan Mariem, Jawad Mahmood Jasem, Hamad Atheer Khdyair
Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
College of Pharmacy, Alnoor University, Nineveh, Iraq.
Biochem Biophys Rep. 2024 Nov 18;40:101871. doi: 10.1016/j.bbrep.2024.101871. eCollection 2024 Dec.
is the perilous pandemics that occurred in Asia and Europe. The bacterium has shown drug resistance that can cause the future pandemic and destroy the drug treatment against plague. As known, effective therapeutics such as designing potent vaccine that can aid world to protect against plague. The immunoinformatics approaches was implemented via different server. The 4 potent antigens (F1 capsule, LcrV, OmpA, and PH6) were listed as essential protein target for creating the multi-epitope vaccine. These targets were selected for designing multi-epitope vaccine that predicted the CTL and HTL epitopes. The vaccine construct included different linkers such as EAAAK, AAY, GPGPG, and SSL that an adjuvant (Beta defensin-3) inserted at N-terminal of vaccine. The computational physiochemical properties and other immunological analysis showed stable, soluble, antigen, non-allergen, and non-toxin. The molecular docking confirmed the stable binding and good interaction and the iMODS server showed the stable binding. Furthermore, computational immune simulation of multi-epitope vaccine showed that vaccine can stimulate adaptive and innate responses after second doses. In this study, the vaccine designed for Y. pestis that in future require immunological examination to unveil real efficiency.
是发生在亚洲和欧洲的危险大流行病。这种细菌已显示出耐药性,可能导致未来的大流行并破坏针对鼠疫的药物治疗。众所周知,有效的治疗方法如设计有效的疫苗可以帮助世界预防鼠疫。免疫信息学方法通过不同的服务器实施。4种有效抗原(F1荚膜、LcrV、OmpA和PH6)被列为创建多表位疫苗的必需蛋白质靶点。选择这些靶点来设计预测CTL和HTL表位的多表位疫苗。疫苗构建体包括不同的接头,如EAAAK、AAY、GPGPG和SSL,一种佐剂(β-防御素-3)插入到疫苗的N端。计算理化性质和其他免疫学分析表明其具有稳定性、可溶性、抗原性、非过敏性和非毒性。分子对接证实了稳定的结合和良好的相互作用,iMODS服务器也显示了稳定的结合。此外,多表位疫苗的计算免疫模拟表明,该疫苗在第二次接种后可刺激适应性和先天性反应。在本研究中,为鼠疫耶尔森菌设计的疫苗未来需要进行免疫学检查以揭示其实际效果。